CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Revenues	$ 2,967,183	$ 3,017,489	$ 6,491,514	$ 5,504,385
Cost of goods sold	348,675	334,829	678,863	624,169
Gross profit	2,618,508	2,682,660	5,812,651	4,880,216
Operating expenses
Selling, general and administrative expense	3,624,027	2,983,248	8,530,565	5,333,611
Depreciation and amortization	74,221	22,542	127,726	26,882
Bad debt expense	0	0	30,000	0
Total operating expenses	3,698,248	3,005,790	8,688,291	5,360,493
Operating loss	(1,079,740)	(323,130)	(2,875,640)	(480,277)
Other expense
Other expense	(48,716)	145	(85,474)	145
Interest expense	(1,101)	(29,486)	(9,455)	(34,911)
Total other expense	(49,817)	(29,341)	(94,929)	(34,766)
Net loss	(1,129,557)	(352,471)	(2,970,569)	(515,043)
Less: net loss attributable to noncontrolling interest	(3,793)	(1,054)	(7,848)	(1,054)
Net loss attributable to Sanara MedTech common shareholders	$ (1,125,764)	$ (351,417)	$ (2,962,721)	$ (513,989)
Basic loss per share of common stock	$ (0.18)	$ (0.15)	$ (0.54)	$ (0.37)
Diluted loss per share of common Stock	$ (0.18)	$ (0.15)	$ (0.54)	$ (0.37)
Weighted average number of common shares outstanding basic	6,203,577	2,366,288	5,477,759	1,398,867
Weighted average number of common shares outstanding diluted	6,203,577	2,366,288	5,477,759	1,398,867